These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 16882104

  • 1. Calcitonin gene-related peptide and somatostatin releases correlated with the area under the lafutidine concentration-time curve in human plasma.
    Ikawa K, Shimatani T, Azuma Y, Inoue M, Morikawa N.
    J Clin Pharm Ther; 2006 Aug; 31(4):351-6. PubMed ID: 16882104
    [Abstract] [Full Text] [Related]

  • 2. Lafutidine, a novel histamine H2-receptor antagonist, increases serum calcitonin gene-related peptide in rats after water immersion-restraint stress.
    Sato H, Kawashima K, Yuki M, Kazumori H, Rumi MA, Ortega-Cava CF, Ishihara S, Kinoshita Y.
    J Lab Clin Med; 2003 Feb; 141(2):102-5. PubMed ID: 12577045
    [Abstract] [Full Text] [Related]

  • 3. Lafutidine, a newly developed antiulcer drug, elevates postprandial intragastric pH and increases plasma calcitonin gene-related peptide and somatostatin concentrations in humans: comparisons with famotidine.
    Shimatani T, Inoue M, Kuroiwa T, Xu J, Nakamura M, Tazuma S, Ikawa K, Morikawa N.
    Dig Dis Sci; 2006 Jan; 51(1):114-20. PubMed ID: 16416222
    [Abstract] [Full Text] [Related]

  • 4. Lafutidine changes levels of somatostatin, calcitonin gene-related peptide, and secretin in human plasma.
    Itoh H, Naito T, Takeyama M.
    Biol Pharm Bull; 2002 Mar; 25(3):379-82. PubMed ID: 11913538
    [Abstract] [Full Text] [Related]

  • 5. Effects of histamine H(2)-receptor antagonists on human plasma levels of calcitonin gene-related peptide, substance P and vasoactive intestinal peptide.
    Itoh H, Naito T, Takeyama M.
    J Pharm Pharmacol; 2002 Nov; 54(11):1559-63. PubMed ID: 12495560
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetic and pharmacodynamic properties of lafutidine after postprandial oral administration in healthy subjects: comparison with famotidine.
    Ikawa K, Shimatani T, Hayato S, Morikawa N, Tazuma S.
    Biol Pharm Bull; 2007 May; 30(5):1003-6. PubMed ID: 17473452
    [Abstract] [Full Text] [Related]

  • 7. Ecabet sodium raises plasma levels of calcitonin generelated peptide and substance P in healthy humans.
    Katagiri F, Inoue S, Sato Y, Itoh H, Takeyama M.
    J Pharm Pharmacol; 2005 Jun; 57(6):799-805. PubMed ID: 15969937
    [Abstract] [Full Text] [Related]

  • 8. Lafutidine, a unique histamine H2-receptor antagonist, inhibits distention-induced gastric acid secretion through an H2 receptor-independent mechanism.
    Nakano M, Kitano S, Nanri M, Kiniwa M.
    Eur J Pharmacol; 2011 May 11; 658(2-3):236-41. PubMed ID: 21349265
    [Abstract] [Full Text] [Related]

  • 9. Sensitizing effects of lafutidine on CGRP-containing afferent nerves in the rat stomach.
    Nishihara K, Nozawa Y, Nakano M, Ajioka H, Matsuura N.
    Br J Pharmacol; 2002 Mar 11; 135(6):1487-94. PubMed ID: 11906962
    [Abstract] [Full Text] [Related]

  • 10. Comparison of effect of an increased dosage of vonoprazan versus vonoprazan plus lafutidine on gastric acid inhibition and serum gastrin.
    Suzuki T, Kagami T, Uotani T, Yamade M, Hamaya Y, Iwaizumi M, Osawa S, Sugimoto K, Miyajima H, Furuta T.
    Eur J Clin Pharmacol; 2018 Jan 11; 74(1):45-52. PubMed ID: 28986609
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of neutrophil activation by lafutidine, an H2-receptor antagonist, through enhancement of sensory neuron activation contributes to the reduction of stress-induced gastric mucosal injury in rats.
    Harada N, Okajima K.
    Dig Dis Sci; 2007 Feb 11; 52(2):469-77. PubMed ID: 17211693
    [Abstract] [Full Text] [Related]

  • 12. Lafutidine increases hepatic blood flow via potentiating the action of central thyrotropin-releasing hormone in rats.
    Yoneda M, Kurosawa M, Watanobe H, Terano A.
    J Gastroenterol Hepatol; 2003 Feb 11; 18(2):177-84. PubMed ID: 12542603
    [Abstract] [Full Text] [Related]

  • 13. Effect of Helicobacter pylori status on intragastric pH during administration of lafutidine or famotidine.
    Koike T, Ohara S, Sehine H, Kawamura M, Abe Y, Inomata Y, Iijima K, Imatani A, Shimosegawa T.
    Hepatogastroenterology; 2007 Jun 11; 54(76):1280-4. PubMed ID: 17629089
    [Abstract] [Full Text] [Related]

  • 14. Lafutidine inhibits Helicobacter pylori-induced interleukin-8 production in human gastric epithelial cells.
    Nozawa Y, Nishihara K, Akizawa Y, Orimoto N, Nakano M, Uji T, Ajioka H, Kanda A, Matsuura N, Kiniwa M.
    J Gastroenterol Hepatol; 2004 May 11; 19(5):506-11. PubMed ID: 15086593
    [Abstract] [Full Text] [Related]

  • 15. Protective effect of lafutidine, a histamine H2 receptor antagonist, against loxoprofen-induced small intestinal lesions in rats.
    Amagase K, Ochi A, Sugihara T, Kato S, Takeuchi K.
    J Gastroenterol Hepatol; 2010 May 11; 25 Suppl 1():S111-8. PubMed ID: 20586851
    [Abstract] [Full Text] [Related]

  • 16. Effect of pilocarpine on substance P and calcitonin gene-related peptide releases correlate with salivary secretion in human saliva and plasma.
    Sato Y, Itoh H, Suzuki Y, Tatsuta R, Takeyama M.
    J Clin Pharm Ther; 2013 Feb 11; 38(1):19-23. PubMed ID: 23030252
    [Abstract] [Full Text] [Related]

  • 17. Effects of a novel histamine H2-receptor antagonist, lafutidine, on the mucus barrier of human gastric mucosa.
    Ichikawa T, Ota H, Sugiyama A, Maruta F, Ikezawa T, Hotta K, Ishihara K.
    J Gastroenterol Hepatol; 2007 Nov 11; 22(11):1800-5. PubMed ID: 17914953
    [Abstract] [Full Text] [Related]

  • 18. Stronger inhibition of gastric acid secretion by lafutidine, a novel H2 receptor antagonist, than by the proton pump inhibitor lansoprazole.
    Yamagishi H, Koike T, Ohara S, Horii T, Kikuchi R, Kobayashi S, Abe Y, Iijima K, Imatani A, Suzuki K, Hishinuma T, Goto J, Shimosegawa T.
    World J Gastroenterol; 2008 Apr 21; 14(15):2406-10. PubMed ID: 18416470
    [Abstract] [Full Text] [Related]

  • 19. [Clinicopharmacological study of gastrointestinal drugs from the viewpoint of postmarketing development].
    Itoh H.
    Yakugaku Zasshi; 2006 Sep 21; 126(9):767-78. PubMed ID: 16946590
    [Abstract] [Full Text] [Related]

  • 20. Palliative effect of lafutidine on oral burning sensation.
    Toida M, Kato K, Makita H, Long NK, Takeda T, Hatakeyama D, Yamashita T, Shibata T.
    J Oral Pathol Med; 2009 Mar 21; 38(3):262-8. PubMed ID: 19175712
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.